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Background
Adenomyosis is a complex disorder that accounts up to
one third of gynecological morbidity. Diffuse form of
adenomyosis is most difficult to diagnose and treat. All
attempts to create a “gold standard” in preserving ther-
apy have not been successful so far. MRgFUS could be a
promising technology for organ-preserving treatment of
this disease.
Purpose of this study was to determine the efficacy of
MRgFUS ablation in organ-preserving treatment of
adenomyosis.
Materials and methods
15 women (25-45 yrs old) with symptomatic adenomyo-
sis were included in the study. Informed consent was
obtained in all cases. The diagnosis and the technical
ability to follow the procedure protocol were confirmed
by MRI. Ablation was performed using ExAblate-2000
(InSightec, Israel) by guidance of 1,5T MRI (General
Electric, USA). Control MRI and Doppler mapping were
performed immediately after and in 3 months after
MRgFUS ablation to evaluate uterine volume and vascu-
larity of myometrium. All the patients completed ques-
tionnaires before and 3 months after the procedure.
Results
12 of 15 pts (80%) reported an improvement of life
quality in 3 months. Regression of pain was observed in
80% of cases (12 pts), a decrease of metrorrhagia - in
60% (9 pts). Recurrence of the symptoms in these
patients was not observed 6 months after treatment.
In 70% of cases (10 pts) the uterine volume decreased
by 33% 3 months after ablation.
In 60% of women (9 pts) non-perfused zones were
described using MRI with contrast-enhancement, aver-
aging 26% of the affected areas. Decrease of vascularity
was confirmed by Doppler mapping technique.
Conclusion
MRgFUS ablation may become a method of choice for
conserving therapy of the patients with a confirmed diag-
nosis of adenomyosis especially in reproductive age. This
method is non-invasive, does not require hospitalization.
This requires further observation and confirmation in a
bigger group of patients and in a long-term period.
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